Sort by:

select Language:



Critically important antimicrobials for human medicine

World Health Organization WHO, (2017)


5th revised edition. This document provides a ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. The current revision took place at the seventh meeting of the AGISAR held in Raleigh, United States of America in 2016.
http://apps.who.int/iris/bitstream/10665/255027/1/...


Integrated surveillance of antimicrobial resistance in foodborne bacteria

World Health Organization WHO, (2017)


Application of a One Health approach . The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in the foodborne bacteria (i.e., bacteria commonly transmitted by food) by taking a One Health approach.
http://apps.who.int/iris/bitstream/10665/255747/1/...


WHO guidelines on use of medically important antimicrobials in food-producing animals

World Health Organization WHO, (2017)


These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve the effectiveness of medically important antimicrobials, particularly those antimicrobials judged to be critically important to human medicine and also help preserve the effectiveness of antimicrobials for veterinary medicine, in direct support of the WHO global action plan on antimicrobial resistance
http://apps.who.int/iris/bitstream/10665/258970/1/...


87 hits